EAM Investors’s CVRx CVRX Stock Holding History

EAM Investors’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-55,831	Closed	-$683K	–	259
2025 Q1	$683K	Buy	+55,831	New	+$789K	0.12%	195
2024 Q1	–	Sell	-140,768	Closed	-$4.43M	–	261
2023 Q4	$4.43M	Buy	+140,768	New	+$2.64M	0.79%	16
2023 Q1	–	Sell	-132,104	Closed	-$2.42M	–	279
2022 Q4	$2.42M	Buy	+132,104	New	+$1.63M	0.5%	62

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EAM Investors's CVRX Position: Q2 2025 in Review

EAM Investors sold out of CVRx (CVRX) in Q2 2025, closing a stake of 55,831 shares — an estimated $683K sold.

EAM Investors first reported a position in CVRX in Q4 2022 and held it in 3 quarters. The position peaked at $4.43M in Q4 2023. 92 funds tracked by Wall St. Rank hold CVRX as of Q2 2025.

EAM Investors reported no remaining CVRx position as of Q2 2025 after selling out during the quarter.
EAM Investors sold 55,831 CVRx shares in Q2 2025, an estimated $683K.
EAM Investors first reported a position in CVRx in Q4 2022 and held it in 3 quarters.
EAM Investors's CVRx position peaked at $4.43M in Q4 2023.
92 funds tracked by Wall St. Rank held CVRx as of Q2 2025.

Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.